IRCT20131113015393N7招募中未知
Comparison of the effectiveness of Xyla-p and cold needle cream on pain intensity during venipuncture in children under chemotherapy
Sabzevar University of Medical Sciences0 个研究点目标入组 80 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 2 years 至 6 years（—）
- 性别
- All
入选标准
- •Aged between 18 to 65 years
- •Have leukemia
- •Outpatients refer to the chemotherapy department
- •Receive chemotherapy every week
- •At least one month has passed since the onset of the disease
排除标准
- •restless children
- •the children with loss of consciousness
- •children receive sedative or analgesic
- •children with a history of sensitivity to lidocaine.
研究者
相似试验
招募中
Unknown
Comparing two different methods of cleaning oral cavity of preterm babies and to check its effect on caries causing microoraganisms.CTRI/2023/06/053365Dr Simran Singh
进行中（未招募）
1 期
A Study to Evaluate the Efficacy and Safety of XyloCore, a Glucose Sparing Experimental Solution, for Peritoneal Dialysis (ELIXIR)End-Stage Kidney DiseaseMedDRA version: 21.1Level: LLTClassification code: 10014646Term: End stage renal disease (ESRD) Class: 10038359CTIS2024-513562-19-00Iperboreal Pharma S.r.l.170
招募中
1 期
Study to evaluate the effIcacy and safety of a solution for peritoneal dialysis with a low glucose contentEUCTR2019-004183-21-ITIPERBOREAL PHARMA S.R.L.170
进行中（未招募）
1 期
A Study to Evaluate the EffIcacy and Safety of XyloCore, a low-glucose solution for peritoneal dialysisEnd-Stage Renal Disease (ESRD)MedDRA version: 21.0Level: PTClassification code 10077512Term: End stage renal diseaseSystem Organ Class: 10038359 - Renal and urinary disordersEUCTR2019-004183-21-DEIperboreal Pharma Srl170
进行中（未招募）
1 期
A Study to Evaluate the EffIcacy and Safety of XyloCore, a low-glucose solution for peritoneal dialysisEnd-Stage Renal Disease (ESRD)MedDRA version: 21.0Level: PTClassification code 10077512Term: End stage renal diseaseSystem Organ Class: 10038359 - Renal and urinary disordersEUCTR2019-004183-21-DKIperboreal Pharma Srl170